DSP NIFTY Healthcare Index Fund - Direct- Growth
DSP Investment Managers Private Limited · Direct Plan · Growth
Fund overview
NIL
Returns & rankings
| Period | Fund Returns | Category Avg. | Rank | VS Category |
|---|---|---|---|---|
| … | ||||
Green = fund outperformed the category average for that period; red = underperformed. Periods under 1 year always show absolute (non-annualised) returns. Past performance does not guarantee future returns.
Return calculator
One-time investment
₹1,000
| Over the past | Total investment | Would've become | Returns |
|---|---|---|---|
| 1 Year | ₹1,000 | ₹1,076 | +76 |
| 3 Years | ₹1,000 | ₹1,247 | +247 |
| 5 Years | ₹1,000 | ₹1,445 | +445 |
Calculated using the fund's annualised return since inception (7.6% p.a.) as period-wise historical returns aren't available in the current feed. Actual returns fluctuate and are not guaranteed. Mutual fund investments are subject to market risks.
Holdings
20 securitiesTop 10 holdings make up 71.8% of the portfolio.
| Security | Sector | Market Cap | Weight |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Pharmaceuticals & Biotechnology | Large Cap | 17.01% |
| Divi'S Laboratories Ltd | Pharmaceuticals & Biotechnology | Large Cap | 10.44% |
| Apollo Hospitals Enterprises Ltd | Healthcare Services | Large Cap | 7.43% |
| Laurus Labs Ltd | Pharmaceuticals & Biotechnology | Mid Cap | 6.82% |
| Cipla Ltd | Pharmaceuticals & Biotechnology | Large Cap | 6.70% |
| Dr. Reddys Laboratories Ltd | Pharmaceuticals & Biotechnology | Mid Cap | 6.65% |
| Torrent Pharmaceuticals Ltd | Pharmaceuticals & Biotechnology | Large Cap | 6.25% |
| Max Healthcare Institute Ltd | Healthcare Services | Mid Cap | 6.12% |
| Lupin Ltd | Pharmaceuticals & Biotechnology | Mid Cap | 4.36% |
| Aurobindo Pharma Ltd | Pharmaceuticals & Biotechnology | Mid Cap | 4.09% |
Portfolio Allocation
Equity / Debt / Cash
Total Value
₹25 Cr
Market Cap Split
Total Value
100%
Equity sector allocation
Total Value
₹25 Cr
Exit load, stamp duty & tax
20-Jun-25
NIL
0.005% (from July 1st, 2020)
Taxation depends on the fund category and holding period. Consult the scheme document or a tax advisor for details.
Risk & Performance Ratios (1Y)
| Standard Deviation | -- |
| Beta | -- |
| Sharpe Ratio | -- |
| Sortino Ratio | -- |
| Treynor Ratio | -- |
| Jensen's Alpha | -- |
| Information Ratio | -- |
| R-Squared | -- |
| Max Drawdown | -- |
| Upside Capture | -- |
| Downside Capture | -- |
Fund management
Scheme Details
Investment objective
The Investment Objective Of The Scheme Is To Generate Returns That Are Commensurate With The Performance Of The Nifty Healthcare Index, Subject To Tracking Error. There Is No Assurance That The Investment Objective Of The Scheme Will Be Achieved.
Fund house
DSP Investment Managers Private Limited
Frequently asked questions
What is the NAV of DSP NIFTY Healthcare Index Fund - Direct- Growth?
The NAV of DSP NIFTY Healthcare Index Fund - Direct- Growth is ₹11.04 as of 21 Oct 2026. NAV is updated at the end of every trading day.
How much expense ratio is charged by DSP NIFTY Healthcare Index Fund - Direct- Growth?
The expense ratio charged by DSP NIFTY Healthcare Index Fund - Direct- Growth is 0.4%.
What is the Min. SIP of DSP NIFTY Healthcare Index Fund - Direct- Growth?
The minimum SIP investment in DSP NIFTY Healthcare Index Fund - Direct- Growth is ₹100 per month.
What is the Min. Lumpsum of DSP NIFTY Healthcare Index Fund - Direct- Growth?
The minimum lumpsum investment in DSP NIFTY Healthcare Index Fund - Direct- Growth is ₹100.
What is the Exit Load of DSP NIFTY Healthcare Index Fund - Direct- Growth?
The exit load for DSP NIFTY Healthcare Index Fund - Direct- Growth is: NIL
.svg){kind=small}